Rani PriyankaVasireddyMDMHA

Instructor

Dr. Vasireddy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Rani Priyanka Vasireddy is a neurologist practicing in Lexington, Kentucky at the University of Kentucky Albert B. Chandler Hospital since 2020. She completed her neurology residency in 2023 at the University of Kentucky College of Medicine, after graduating from the Kamineni Institute of Medical Science in 2010. Dr. Vasireddy's notable contributions in research include her publications on Parkinsonism and NMDA Positive encephalitis, and a clinical trial examining a potential role for Amylin in Diabetic Peripheral Neuropathy.

PubMed

3 citations
New generation VMAT2 inhibitors induced parkinsonism.
Rani Priyanka Vasireddy, Brent S. Sokola, Zain Guduru
Clinical Parkinsonism & Related Disorders. 2020-11-07
Pearls & Oy-sters: Bibrachial Amyotrophy From a Dural Tear.
Yuyao Sun, Shivani Pahwa, Rani Priyanka Vasireddy, Andrew Barty, Flavius D Raslau
Neurology. 2024-04-09

Abstracts/Posters

Parkinsonism secondary to use of valbenazine and reversal with the addition of levodopa: A Case Report (1183)
Rani Priyanka Vasireddy, Zain Guduru, AAN 2020, 4/14/2020
Infant presenting with Autoimmune NMDA Positive encephalitis secondary to Herpes Simplex Encephalitis: A Case Report (1103)
Rani Priyanka Vasireddy, Zain Guduru, Qutubuddin Khan, AAN 2020, 4/14/2020

Sub InvestigatorSafety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis2019 - Present
sub investigatorA Causative Role for Amylin in Diabetic Peripheral Neuropathy2019 - Present
Sub investigatorA Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis2019 - Present
Sub InvestigatorA Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis2019 - Present